col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


37 Results       Page 1

 [1] 
Springer Science and Business Media LLC: Communications Medicine
  original article Date Title Authors   All Authors
1 [GO] 2022―May―19 Estimating the COVID-19 infection fatality ratio accounting for seroreversion using statistical modelling Nicholas F. Brazeau, Robert Verity, Sara Jenks, Han Fu, Charles Whittaker, Peter Winskill, et al. (+16)
2 [GO] 2022―May―19 Trajectory patterns of SARS-CoV-2 neutralising antibody response in convalescent COVID-19 patients Ngai Sze Wong, Shui Shan Lee, Denise P. C. Chan, Timothy C. M. Li, Tracy H. Y. Ho, Fion W. L. Luk, et al. (+6)
3 [GO] 2022―May―18 German federal-state-wide seroprevalence study of 1st SARS-CoV-2 pandemic wave shows importance of long-term antibody test performance Stefan Lohse, Anna Sternjakob-Marthaler, Paul Lagemann, Jakob Schöpe, Jürgen Rissland, Nastasja Seiwert, et al. (+18)
4 [GO] 2022―May―12 Using a 5G network in hospitals to reduce nosocomial infection during the COVID-19 pandemic Li Wen, Zhiwen Ou, Wenzhou Duan, Weijie Zhu, Xiongzhi Xiao, Ying Zhang, et al. (+3)
5 [GO] 2022―Apr―13 Impact of SARS-CoV-2 Gamma lineage introduction and COVID-19 vaccination on the epidemiological landscape of a Brazilian city Cecília Artico Banho, Lívia Sacchetto, Guilherme Rodrigues Fernandes Campos, Cíntia Bittar, Fábio Sossai Possebon, Leila Sabrina Ullmann, et al. (+29)
6 [GO] 2022―Apr―05 An olfactory self-test effectively screens for COVID-19 Kobi Snitz, Danielle Honigstein, Reut Weissgross, Aharon Ravia, Eva Mishor, Ofer Perl, et al. (+23)
7 [GO] 2022―Apr―05 A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern Nina Urke Ertesvåg, Julie Xiao, Fan Zhou, Sonja Ljostveit, Helene Sandnes, Sarah Lartey, et al. (+49)
8 [GO] 2022―Mar―14 Utilizing wearable sensors for continuous and highly-sensitive monitoring of reactions to the BNT162b2 mRNA COVID-19 vaccine Yftach Gepner, Merav Mofaz, Shay Oved, Matan Yechezkel, Keren Constantini, Nir Goldstein, et al. (+3)
9 [GO] 2022―Mar―03 Risk assessment of COVID-19 epidemic resurgence in relation to SARS-CoV-2 variants and vaccination passes Tyll Krueger, Krzysztof Gogolewski, Marcin Bodych, Anna Gambin, Giulia Giordano, Sarah Cuschieri, et al. (+5)
10 [GO] 2022―Feb―22 BNT162b2 vaccination enhances interferon-JAK-STAT-regulated antiviral programs in COVID-19 patients infected with the SARS-CoV-2 Beta variant Ludwig Knabl, Hye Kyung Lee, Manuel Wieser, Anna Mur, August Zabernigg, Ludwig Knabl, et al. (+6)
11 [GO] 2022―Feb―10 Modelling the impact of vaccine hesitancy in prolonging the need for Non-Pharmaceutical Interventions to control the COVID-19 pandemic Daniela Olivera Mesa, Alexandra B. Hogan, Oliver J. Watson, Giovanni D. Charles, Katharina Hauck, Azra C. Ghani, Peter Winskill
12 [GO] 2022―Jan―28 SARS-CoV-2 introductions and early dynamics of the epidemic in Portugal Vítor Borges, Joana Isidro, Nídia Sequeira Trovão, Sílvia Duarte, Helena Cortes-Martins, Hugo Martiniano, et al. (+148)
13 [GO] 2022―Jan―12 Clinical validation of engineered CRISPR/Cas12a for rapid SARS-CoV-2 detection Long T. Nguyen, Santosh R. Rananaware, Brianna L. M. Pizzano, Brandon T. Stone, Piyush K. Jain
14 [GO] 2022―Jan―10 A 2-month field cohort study of SARS-CoV-2 in saliva of BNT162b2 vaccinated nursing home workers Claude Saegerman, Anh Nguyet Diep, Véronique Renault, Anne-Françoise Donneau, Lambert Stamatakis, Wouter Coppieters, et al. (+13)
15 [GO] 2021―Dec―09 Extensive Mendelian randomization study identifies potential causal risk factors for severe COVID-19 Yitang Sun, Jingqi Zhou, Kaixiong Ye
16 [GO] 2021―Dec―06 Adherence and sustainability of interventions informing optimal control against the COVID-19 pandemic Laura Di Domenico, Chiara E. Sabbatini, Pierre-Yves Boëlle, Chiara Poletto, Pascal Crépey, Juliette Paireau, et al. (+5)
17 [GO] 2021―Nov―25 Prior fluid and electrolyte imbalance is associated with COVID-19 mortality Satu Nahkuri, Tim Becker, Vitalia Schueller, Steffen Massberg, Anna Bauer-Mehren
18 [GO] 2021―Nov―15 A case report describing the immune response of an infant with congenital heart disease and severe COVID-19 Danielle Wurzel, Melanie R. Neeland, Jeremy Anderson, Yara-Natalie Abo, Lien Anh Ha Do, Celeste M. Donato, et al. (+25)
19 [GO] 2021―Nov―15 Model-based estimation of transmissibility and reinfection of SARS-CoV-2 P.1 variant Renato Mendes Coutinho, Flavia Maria Darcie Marquitti, Leonardo Souto Ferreira, Marcelo Eduardo Borges, Rafael Lopes Paixão da Silva, Otavio Canton, et al. (+9)
20 [GO] 2021―Nov―11 A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies Patthara Kongsuphol, Huan Jia, Hoi Lok Cheng, Yue Gu, Bhuvaneshwari D/O Shunmuganathan, Ming Wei Chen, et al. (+15)
21 [GO] 2021―Oct―29 Direct SARS-CoV-2 infection of the human inner ear may underlie COVID-19-associated audiovestibular dysfunction Minjin Jeong, Karen E. Ocwieja, Dongjun Han, P. Ashley Wackym, Yichen Zhang, Alyssa Brown, et al. (+10)
22 [GO] 2021―Oct―26 Host methylation predicts SARS-CoV-2 infection and clinical outcome Iain R. Konigsberg, Bret Barnes, Monica Campbell, Elizabeth Davidson, Yingfei Zhen, Olivia Pallisard, et al. (+25)
23 [GO] 2021―Oct―15 The risk of SARS-CoV-2 outbreaks in low prevalence settings following the removal of travel restrictions Rahil Sachak-Patwa, Helen M. Byrne, Louise Dyson, Robin N. Thompson
24 [GO] 2021―Oct―13 Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve Luca Dalle Carbonare, Maria Teresa Valenti, Zeno Bisoffi, Chiara Piubelli, Massimo Pizzato, Silvia Accordini, et al. (+14)
25 [GO] 2021―Oct―05 Genetic and phenotypic analysis of the causal relationship between aging and COVID-19 Kejun Ying, Ranran Zhai, Timothy V. Pyrkov, Anastasia V. Shindyapina, Marco Mariotti, Peter O. Fedichev, et al. (+2)
26 [GO] 2021―Sep―22 Reduced subgenomic RNA expression is a molecular indicator of asymptomatic SARS-CoV-2 infection Chee Hong Wong, Chew Yee Ngan, Rachel L. Goldfeder, Jennifer Idol, Chris Kuhlberg, Rahul Maurya, et al. (+8)
27 [GO] 2021―Sep―17 The antibody response to SARS-CoV-2 infection persists over at least 8 months in symptomatic patients Riccardo Levi, Leonardo Ubaldi, Chiara Pozzi, Giovanni Angelotti, Maria Teresa Sandri, Elena Azzolini, et al. (+4)
28 [GO] 2021―Sep―16 SARS-CoV-2 transmission dynamics in Belarus in 2020 revealed by genomic and incidence data analysis Alina Nemira, Ayotomiwa Ezekiel Adeniyi, Elena L. Gasich, Kirill Y. Bulda, Leonid N. Valentovich, Anatoly G. Krasko, et al. (+3)
29 [GO] 2021―Sep―09 Exploratory study of the global intent to accept COVID-19 vaccinations Alexandre de Figueiredo, Heidi J. Larson
30 [GO] 2021―Aug―23 Characterization of SARS-CoV-2 and host entry factors distribution in a COVID-19 autopsy series Xiao-Ming Wang, Rahul Mannan, Lanbo Xiao, Eman Abdulfatah, Yuanyuan Qiao, Carol Farver, et al. (+12)
31 [GO] 2021―Aug―19 A spatial and dynamic solution for allocation of COVID-19 vaccines when supply is limited Wenzhong Shi, Chengzhuo Tong, Anshu Zhang, Zhicheng Shi
32 [GO] 2021―Jul―16 High coverage COVID-19 mRNA vaccination rapidly controls SARS-CoV-2 transmission in long-term care facilities Pablo M. De Salazar, Nicholas B. Link, Karuna Lamarca, Mauricio Santillana
33 [GO] 2021―Jul―14 Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults Angelika Wagner, Angela Guzek, Johanna Ruff, Joanna Jasinska, Ute Scheikl, Ines Zwazl, et al. (+6)
34 [GO] 2021―Jul―07 Vaccinate fast but leave no one behind: a call to action for COVID-19 vaccination in Spain Jeffrey V. Lazarus, Quique Bassat, Javier Crespo, Gonzalo Fanjul, Alberto L. Garcia-Basteiro, Marcos López Hoyos, et al. (+8)
35 [GO] 2021―Jun―30 Analysis of sex-specific risk factors and clinical outcomes in COVID-19 Tomi Jun, Sharon Nirenberg, Tziopora Weinberger, Navya Sharma, Elisabet Pujadas, Carlos Cordon-Cardo, et al. (+2)
36 [GO] 2021―Jun―30 The autumnal lockdown was not the main initiator of the decrease in SARS-CoV-2 circulation in France Veronica Pereda-Loth, Aldair Martínez Pineda, Lenka Tisseyre, Monique Courtade-Saidi, Christophe Bousquet, Camille Ferdenzi, et al. (+3)
37 [GO] 2021―Jun―30 High SARS-CoV-2 seroprevalence in children and adults in the Austrian ski resort of Ischgl Ludwig Knabl, Tanmay Mitra, Janine Kimpel, Annika Rössler, André Volland, Andreas Walser, et al. (+12)
 [1] 

37 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.006 sec